ArticleTrials2023

Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor's cellular immunotherapy products: the MDR-105-SAE.

Sam Kant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.